Media Releases Archive | InSphero
Feb 01, 2016

February 01, 2016 – InSphero Inc. Streamlines 3D Microtissue Business Operations in US

InSphero Inc. Streamlines 3D Microtissue Business Operations in US Schlieren, Switzerland, February 01, 2016 – US subsidiary of Swiss-based InSphero AG initiates direct product shipments, progresses towards full-scale US bioproduction […]

Read More
 
 
Jan 25, 2016

January 25, 2016 – InSphero and NCATS to Present Collaborative 3D Cancer Screening Study at SLAS2016 Annual Meeting

InSphero and NCATS to Present Collaborative 3D Cancer Screening Study at SLAS2016 Annual Meeting Schlieren, Switzerland, January 25, 2016 – Study describes high-throughput compatible screening assay using 3D tumor microtissue […]

Read More
 
 
Jan 21, 2016

January 21, 2016 – InSphero Adds Head of Sales, Expands Global Sales Team

InSphero Adds Head of Sales, Expands Global Sales Team Schlieren, Switzerland, January 21, 2016 – Beate Schnell, Ph.D. joins senior team at global leader in 3D cell culture, announces new […]

Read More
 
 
Oct 23, 2015

October 23, 2015 – InSphero’s CEO Jan Lichtenberg wins Entrepreneur Of The Year™ 2015

InSphero's CEO Jan Lichtenberg wins Entrepreneur of the Year™ 2015 Schlieren, Switzerland, Oct 23, 2015 – Dr. Jan Lichtenberg, CEO and co-founder of InSphero AG received the Ernst & Young […]

Read More
 
 
Oct 21, 2015

October 21, 2015 – InSphero Receives € 750K Funding from EU-ToxRisk Consortium

InSphero Receives € 750K Funding from EU-ToxRisk Consortium Schlieren, Switzerland, Oct 21, 2015 – In a large (€ 30 MM) H2020-supported collaborative project, leading 3D cell culture technology provider joins […]

Read More
 
 
Oct 15, 2015

October 15, 2015 – InSphero Adds Chief Financial Officer to Senior Management Team

InSphero Adds Chief Financial Officer to Senior Management Team Schlieren, Switzerland, Oct 15, 2015 – Oliver Krähenbühl brings 25 years of finance experience in the technology industry, strengthens senior team […]

Read More
 
 
Oct 13, 2015

October 13, 2015 – InSphero Launches 14 Day Hepatotoxicity Testing Service

InSphero Launches 14 Day Hepatotoxicity Testing Service Schlieren, Switzerland, Oct 13, 2015 – Monthly contract screening service simplifies long-term, repeat-dose testing of drugs in 3D human liver microtissues for global pharmaceutical market. […]

Read More
 
 
Sep 29, 2015

September 29, 2015 – InSphero Granted Hanging Drop Patent in United States

InSphero Granted Hanging Drop Patent in United States Schlieren, Switzerland, September 29, 2015 – Patent establishes protection of InSphero GravityPLUSTM technology in all major global markets, key milestone for leading provider of […]

Read More
 
 
Aug 05, 2015

August 05, 2015 – InSphero Expands Global Availability of its Patented 3D Cell Culture Platforms

InSphero Expands Global Availability of its Patented 3D Cell Culture Platforms Schlieren, Switzerland, August 5, 2015 – PerkinElmer named as exclusive distributor of InSphero state-of-the-art 3D culture technology. PDF Version InSphero AG, the […]

Read More
 
 
Jul 08, 2015

July 08, 2015 – InSphero AG Secures CHF 20 Million Series C Financing

InSphero AG Secures CHF 20 Million Series C Financing Schlieren, Switzerland, July 8, 2015 – Leading 3D cell culture company gains new long-term investor to fuel expansion of global operations and product […]

Read More